New Blood Test May Be Better Able To Detect Increased Risk of Miscarriage Interview with:
Dr. Ali Abbara
Imperial College London, United Kingdom

Dr. Abbara: What are the main findings of the study?

MedicalResearch: We found that a novel blood test for kisspeptin was able to identify asymptomatic pregnant women who were at increased risk of subsequent miscarriage. Blood kisspeptin performed better than the more commonly measured pregnancy hormone BHCG in identifying women at increased risk of miscarriage. 
MedicalResearch: Were any of the findings unexpected?

Dr. Abbara: The study results were consistent with previous basic science research suggesting that kisspeptin may be an important regulator of normal placental formation.

MedicalResearch: What should clinicians and patients take away from your report?

Dr. Abbara: Blood kisspeptin levels may be a useful screening test to identify women at increased risk of miscarriage.

MedicalResearch: What recommendations do you have for future research as a result of this study?

Dr. Abbara: This study opens up a novel avenue of research which will assess whether identifying women at increased risk of miscarriage at an early enough stage in the miscarriage process would allow us to target investigations and treatments which may alter the course of pregnancy in these women.


Abstract presented at the 2014 ICE/Endo

OR04-2 Plasma Kisspeptin Measurement during Early Pregnancy Is a Highly Predictive Marker of Subsequent Miscarriage

Program: Abstracts – Orals, Poster Preview Presentations, and Posters
Session: OR04-Female Reproductive Endocrinology

Saturday, June 21, 2014: 11:30 AM-1:00 PM

Last Updated on June 23, 2014 by Marie Benz MD FAAD